FRDEEN
Swiss Medtech
For a strong Swiss medtech industry
SWISS MEDTECH was established on 12 June 2017 following the merger of two national medtech organizations, FASMED and Medical Cluster. The new association represents the interests of the Swiss medtech industry. The aim is to maintain international competitiveness, innovative capacity, and to strengthen the domestic market.
Image source: BVMed
Image source: BVMed

Whether it be syringes, implants, wheelchairs, or MRIs - medical technology supplies people, doctors, and hospitals with vital products and applications. The domestic medtech industry generates annual sales of 14.1 billion and exports of 10.6 billion Swiss francs. It contributes 2.2% of the GDP. Swiss Medtech supports the Swiss medtech industry's continuing contribution to health care and the economy, as well as its ability to remain competitive internationally.

The Association represents the interests of the industry and serves 1,350 companies and 54,500 employees. It is committed to rapid patient access to innovation and high-quality standards. Swiss Medtech also initiates specialised training programmes, challenges rising levels of regulation, and pushes for free trade and fair tariffs. Together with its specialist groups and partners, the Association is committed to favourable conditions and to an attractive setting for research and other professional activities within Switzerland.

More in "About Us"
News

Swiss innovation champion of medical technology

7.12.17 - From Joseph-F.-B. Charrière to Maurice E. Mueller: For two hundred years, local pioneers have shaped the history of orthopaedics and other areas of medtech with groundbreaking inventions.
 

MDR / IVDR: Medtech Europe calls for measures for timely implementation

27.11.17 The European Medtech Association expects that the EU Commission and the national authorities provide the necessary resources for the introduction of the two EU regulations to guarantee the availability of Notified Bodies as well as seamless patient access to products.
 

Notified Bodies can apply for their names

24.11.17 The EU Commission has published the Codes for Notified Bodies (NB) in the defined jurisdiction for medical devices. As a result, the NB (who certify manufacturers and their medical devices) can apply for their (new) designation following the MDR / IVDR on 26 November 2017, see "implem. measures".


Combined products: highly innovative, but complex

22.11.17At the annual conference of Swiss Medtech and SFL's "Medtech & Pharma Platform", experts from industry and authorities presented the latest technologies and trends, and discussed the regulatory challenges in this growing interface area.
 

Diabetes: Promoting structured self-sufficiency

14.11.17Early detection is one of the topics of the todays World Diabetes Day. The purpose of the SwIss Medtech "Diabetes Self-Management" Specialist Group is to help people suffering from this chronic illness to become self-sufficient.

 

⇒ Mehr News ⇒ Medienmitteilungen

 

Events

Der Weg zu einer nivellierten und synchronen Produktion im Kundentakt
23 January 2018
THE Conference of the Swiss Medtech Industry
12 June 2018